Compare KEP & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KEP | WST |
|---|---|---|
| Founded | 1961 | 1923 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 20.2B |
| IPO Year | N/A | N/A |
| Metric | KEP | WST |
|---|---|---|
| Price | $17.26 | $266.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $346.78 |
| AVG Volume (30 Days) | 427.1K | ★ 633.6K |
| Earning Date | 11-14-2025 | 10-23-2025 |
| Dividend Yield | 0.28% | ★ 0.33% |
| EPS Growth | ★ 122.08 | 0.17 |
| EPS | ★ 9.13 | 6.75 |
| Revenue | ★ $69,245,145,923.00 | $3,017,900,000.00 |
| Revenue This Year | $5.38 | $7.01 |
| Revenue Next Year | $2.36 | $6.20 |
| P/E Ratio | ★ $3.79 | $39.41 |
| Revenue Growth | ★ 5.27 | 4.92 |
| 52 Week Low | $6.68 | $187.43 |
| 52 Week High | $18.29 | $348.90 |
| Indicator | KEP | WST |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 44.15 |
| Support Level | $17.13 | $269.08 |
| Resistance Level | $17.83 | $285.54 |
| Average True Range (ATR) | 0.37 | 7.70 |
| MACD | -0.11 | -0.26 |
| Stochastic Oscillator | 50.83 | 40.50 |
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.